Zombie Cells: What They Are and What Senolytics Might Do About Them
Pull up a chair. I'm 70 years old, and I've spent about 15 years reading the research on aging. I used to sell for a living, so I know a sales pitch when I see one. I'll give you the straight story, hype left out.
Today we're talking about zombie cells. Yes, that's a real thing. Even the Mayo Clinic calls them that.
So what's a zombie cell?
Your body is made of trillions of cells, and most of them do their job, wear out, and get cleaned up. Some cells, though, get damaged and stop dividing, yet they don't die. Scientists call them "senescent" cells. The rest of us can call them zombies.
They hang around in your tissues and don't work right anymore. They also make trouble for the healthy cells around them.
Why are they a problem?
Picture a grumpy neighbor who stopped mowing his lawn years ago and spends all day yelling over the fence. That's a zombie cell.
The yelling has a fancy name: the "SASP," short for senescence-associated secretory phenotype. Don't worry about the name. It just means these cells leak inflammatory signals into the neighborhood. Researchers say that leakage can drive inflammation and keep the tissue around them from working well.
Zombie cells pile up as we get older. They also pile up in places where chronic disease takes hold. Mayo Clinic researchers have tied them to bone and muscle weakness, memory decline, and frailty.
Enter the senolytics
"Senolytic" just means "zombie-cell clearer." These are drugs or natural compounds meant to knock out the zombies and leave the healthy cells alone.
In mice, the results have been eye-popping. Clearing these cells improved health and even lifespan in study after study. That's why so many folks are excited.
Here are the main ones being tested:
Dasatinib plus quercetin ("D+Q"). Dasatinib is a prescription drug. Researchers give the two together for just a few days at a time, a "hit-and-run" approach.
Fisetin. This is another plant compound. One review counted 32 studies of it listed on ClinicalTrials.gov.
What's happened in actual people?
This is where the Elder Dude gets honest with you. Mice aren't people.
In a tiny 2019 Mayo study of 9 people with diabetic kidney disease, 3 days of D+Q lowered zombie-cell counts in fat and skin samples. It also lowered some of those inflammatory "yelling" signals in the blood. That was a real first.
In a 2025 study of 60 older women, D+Q did not make a lasting difference in bone health. A bone-building marker went up for the first few weeks, and by week 20 it was back even with the women who got nothing. The National Institute on Aging called the effect "subtle."
In a 2025 pilot of 12 older adults at risk for Alzheimer's, D+Q looked safe. Memory scores rose a little, but not by enough to count, and there was no comparison group.
In a trial of 74 people with knee arthritis, fisetin didn't improve pain, function, or cartilage.
A 2025 review summed it up this way: only 9 senolytic trials had been published, and only 2 of them had a control group. So far the drugs look fairly safe, and they've shown some hopeful signs in the blood. They haven't yet proven they make people healthier.
The bottom line is that the research is early, mixed, and mostly small. Anybody selling you a "zombie cell cleanse" in a bottle is ahead of the science.
What can you do today?
There is one zombie-fighter with good evidence behind it, and it's free: exercise.
Mayo Clinic researchers put 34 older adults (average age 67) on 12 weeks of strength and endurance training. Their blood markers of zombie cells went down. Their strength and get-up-and-go improved, and they reported less fatigue.
That study also had no comparison group, so it isn't the final word. Still, it lines up with what your grandmother told you. Keep moving, lift something heavy-ish a couple of times a week, and don't let the couch win.
One more thing
I'm a curious old guy, not a doctor, and this isn't medical advice. Dasatinib is a real prescription drug. Even "natural" supplements can mix badly with your medicines. Talk to your doctor before you try any of this.
I'll keep reading the studies so you don't have to. Stick around.
— Elder Dude, Senolytics.com
Sources
1. National Institute on Aging, "Senolytic therapy shows subtle impact on age-related bone health in women" (Feb 27, 2025): https://www.nia.nih.gov/news/senolytic-therapy-shows-subtle-impact-age-related-bone-health-women
2. Hickson et al., "Senolytics decrease senescent cells in humans," EBioMedicine (2019): https://doi.org/10.1016/j.ebiom.2019.08.069
3. Millar et al., "A pilot study of senolytics to improve cognition and mobility in older adults at risk for Alzheimer's disease," eBioMedicine (2025): https://doi.org/10.1016/j.ebiom.2025.105612
4. Khosla, "Translating Senolytics From Mice to Humans" (2025): https://pmc.ncbi.nlm.nih.gov/articles/PMC12759346/
5. Englund et al., "Exercise reduces circulating biomarkers of cellular senescence in humans," Aging Cell (2021): https://pubmed.ncbi.nlm.nih.gov/34101960/
6. Tashman et al., "Results from a randomized clinical trial evaluating the senolytic fisetin for treating knee osteoarthritis," Osteoarthritis and Cartilage (2025 abstract): https://www.oarsijournal.com/article/S1063-4584(25)00692-2/fulltext
Comments